From Vision to Approval: Building the Right Regulatory & Clinical Evidence

Join the Respiradigm team with guest speaker Hugo LeMessurier for a candid & insightful discussion on regulatory & clinical trials strategy.

In this panel, Respiradigm will share what the team is building and why a robust regulatory and clinical trials strategy is non‑negotiable if you want to move fast without costly missteps.

Expect a candid discussion focused on clarity, sequencing, and capital efficiency, so the next steps are the right steps.